Lara Buermann

Lara Buermann is a Research Fellow and computational biologist at the University of Southampton, affiliated with the School of Cancer Sciences under Professor Sean Lim. Her work focuses on applying (epi)genomic, transcriptomic, and single-cell analysis techniques to study the impact of monoclonal antibody therapies in relapsed/refractory lymphoma patients.

Her research integrates advanced data analysis methods to address challenges in cancer treatment efficacy and prognosis. Notable recent contributions include a 2024 publication in the Journal of Medicinal Chemistry exploring novel covalent inhibition strategies for BTK signaling pathways.